These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21688482)

  • 1. [Calcineurin inhibitor nephrotoxicity in nephrotic syndrome].
    Ogahara S; Hisano S; Saito T
    Nihon Jinzo Gakkai Shi; 2011; 53(4):615-9. PubMed ID: 21688482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcineurin inhibitor nephrotoxicity in renal allografts].
    Takeda A; Morozumi K
    Nihon Jinzo Gakkai Shi; 2011; 53(4):610-4. PubMed ID: 21688481
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical markers of renal tubular injury and cyclosporin nephrotoxicity in kidney allograft biopsies.
    García Del Moral R; Navarro N; Montes A; Aguilar D; Aneiros J
    Nephron; 1992; 62(1):121-2. PubMed ID: 1436283
    [No Abstract]   [Full Text] [Related]  

  • 4. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
    Muñoz Díaz AB; Aguilar P
    Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
    Coates PT;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286
    [No Abstract]   [Full Text] [Related]  

  • 6. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts.
    Liptak P; Ivanyi B
    Nat Clin Pract Nephrol; 2006 Jul; 2(7):398-404; quiz following 404. PubMed ID: 16932468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors].
    Snanoudj R; Rabant M; Royal V; Pallet N; Noël LH; Legendre C
    Nephrol Ther; 2009 Dec; 5 Suppl 6():S365-70. PubMed ID: 20129447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.
    Sharma A; Jain S; Gupta R; Guleria S; Agarwal S; Dinda A
    Indian J Pathol Microbiol; 2010; 53(4):651-7. PubMed ID: 21045386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):759-71. PubMed ID: 3291311
    [No Abstract]   [Full Text] [Related]  

  • 10. Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome.
    Jeong HJ; Kim JH; Kim PK; Choi IJ
    Clin Nephrol; 2001 Apr; 55(4):289-96. PubMed ID: 11334314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin-related nephrotoxicity in children with nephrotic syndrome.
    Ganesan V; Milford DV; Taylor CM; Hulton SA; Parvaresh S; Ramani P
    Pediatr Nephrol; 2002 Mar; 17(3):225-6; author reply 227. PubMed ID: 11956868
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential diagnosis of kidney transplant rejection and cyclosporine nephrotoxicity by urine cytology.
    Kyo M; Gudat F; Dalquen P; Fujimoto N; Ichikawa Y; Fukunishi T; Nagano S; Mihatsch MJ
    Transplant Proc; 1992 Aug; 24(4):1388-90. PubMed ID: 1496596
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine A induced histological changes of Cathepsin L and CD2AP expression in renal glomeruli and tubules.
    Sugimoto K; Miyazawa T; Enya T; Miyazaki K; Okada M; Takemura T
    Clin Exp Nephrol; 2017 Feb; 21(1):83-91. PubMed ID: 26975192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic calcineurin inhibitor use is nephrotoxic.
    Chapman JR
    Clin Pharmacol Ther; 2011 Aug; 90(2):207-9. PubMed ID: 21772296
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation.
    Mitome J; Yamamoto H; Maruyama Y; Kobayashi A; Yaginuma T; Matsuo N; Tanno Y; Hayakawa H; Miyazaki Y; Yokoyama K; Utsunomiya Y; Yamaguchi Y; Hosoya T
    Clin Transplant; 2010 Jul; 24 Suppl 22():48-53. PubMed ID: 20590695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytophotometric study of chronic tubular nephropathy simulating a premalignant state].
    Károlyi P; Hegedüs G; Szentirmay Z; Deák G
    Morphol Igazsagugyi Orv Sz; 1988 Oct; 28(4):276-81. PubMed ID: 3185575
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of chronic nephrotoxicity of long-term cyclosporine A treatment in adult patients with steroid-dependent nephrotic syndrome.
    Okada T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T; Nakao T
    Nephrology (Carlton); 2011 Mar; 16(3):319-25. PubMed ID: 21077987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transforming growth factor-beta and determination of apoptotic index in histopathological sections for assessment of the effects of Apigenin (4', 5', 7'- Trihydroxyflavone) on Cyclosporine A induced renal damage.
    Chong FW; Chakravarthi S; Nagaraja HS; Thanikachalam PM; Lee N
    Malays J Pathol; 2009 Jun; 31(1):35-43. PubMed ID: 19694312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
    Hesselink DA; Bouamar R; van Gelder T
    Ther Drug Monit; 2010 Aug; 32(4):387-93. PubMed ID: 20571464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.